table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID 19 all comersCOVID-19 mild to moderateCOVID-19 severe or critically
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderateCOVID-19 severe or critically
tocilizumab Rutgers NCT04479358 ... Martinez-Sanz EMPACTA NCT04434717 ... Tsai NCT04412772 ... HNF Hospital Tocilizumab multidisciplinary team RECOVERY Declercq J ... Dongsheng Wang SAM-COVID-19 Soin AS ... NCT04577534 ... Colaneri EU-CTR2020-001375-32 ... RCT-TCZ-COVID-19 EU-CTR2020-001748-24 ... BACC Bay Tocilizumab Trial TOCOVID Capra TOCI-RAF Study Group ... Andrew CORIMUNO-TOCI-1 ... Sarhan Hamed Rojas-Marte MARIPOSA REMAP-CAP ... Karampitsakos CORIMUNO-TOCI-ICU ... Somers Veiga NCT04377750 ... Biran Rosas ... Karakike ... COVACTA ... Rashad Belhassen-Garc??a Mathilde Pereira Talaschian Sarhan

3 studies excluded by filtering options 2

5494 BREATH-19 Study, 0 2300excludednot a RCTrisk of bias not avaialble
5632 Holt, 2020 2130excludednot a RCTrisk of bias not avaialble
5672 Klopfenstein, 2020 2134excludednot a RCThigh risk of bias

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons